LipoSEARCH®; Analytical GP-HPLC method for lipoprotein profiling and its applications

1 Skylight Biotech Inc., 100-4 Sunada, Iijima, Akita 011-0911, Japan 2 Spectrum Lab. Japan Inc., 1-5-22-201 Midorigaoka, Meguro-ku, Tokyo 152-0034, Japan 3 Veterinary Internal Medicine, Nippon Veterinary and Life Science University, 1-7-1 Kyonan-cho, Musashino, Tokyo 180-8602, Japan 4 Akita Research Institute of Food & Brewing, 4-26 Sanuki, Araya-machi, Akita 010-1623, Japan 5 Department of Medical Technology, Okayama University Graduate School of Health Sciences, 2-5-1, Shikata-cho, Kita-ku, Okayama 700-8558, Japan 6 Professor emeritus of Tokyo Medical and Dental University, Tokyo Medical and Dental University M&D Tower 14th floor, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510, Japan

[1]  M. Ono,et al.  Severe Hypercholesterolemia, Impaired Fat Tolerance, and Advanced Atherosclerosis in Mice Lacking Both Low Density Lipoprotein Receptor-related Protein 5 and Apolipoprotein E* , 2003, The Journal of Biological Chemistry.

[2]  M. Okazaki,et al.  High-performance liquid chromatography of serum lipoproteins. , 1986, Methods in enzymology.

[3]  Huijun Sun,et al.  Overexpression of Lipoprotein Lipase in Transgenic Rabbits Inhibits Diet-induced Hypercholesterolemia and Atherosclerosis* , 2001, The Journal of Biological Chemistry.

[4]  K. Nakajima,et al.  Hypertriglyceridemia in pregnancy does not contribute to the enhanced formation of remnant lipoprotein particles. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[5]  S. Yokoyama,et al.  Effect of Probucol in Lecithin-Cholesterol Acyltransferase–Deficient Mice: Inhibition of 2 Independent Cellular Cholesterol–Releasing Pathways In Vivo , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[6]  K. Nakajima,et al.  Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC. , 2000, Clinica chimica acta; international journal of clinical chemistry.

[7]  L. Wilkins.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994 .

[8]  I. Yoshimura,et al.  Application of gel permeation HPLC for lipoprotein profiling in dogs. , 2010, The Journal of veterinary medical science.

[9]  R. Krauss,et al.  Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. , 1996, JAMA.

[10]  G. Miller,et al.  PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASE , 1975, The Lancet.

[11]  I. Sakurabayashi,et al.  Evaluation of a gel-permeation high-performance liquid chromatography for determining triglyceride levels in serum major lipoproteins, compared with the ultracentrifugation/precipitation method. , 2009, Clinical biochemistry.

[12]  G. Wolfbauer,et al.  Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. , 1987, Journal of lipid research.

[13]  L. Wilkins,et al.  National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II). , 1994, Circulation.

[14]  H. Orimo,et al.  Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes. , 2003, Diabetes research and clinical practice.

[15]  Mitsuyo Okazaki,et al.  A new on-line dual enzymatic method for simultaneous quantification of cholesterol and triglycerides in lipoproteins by HPLC. , 2002, Journal of lipid research.

[16]  S. Yokoyama,et al.  On the hepatic mechanism of HDL assembly by the ABCA1/apoA-I pathway Published, JLR Papers in Press, November 1, 2004. DOI 10.1194/jlr.M400402-JLR200 , 2005, Journal of Lipid Research.

[17]  P. Wilson,et al.  High density lipoprotein cholesterol and mortality. The Framingham Heart Study. , 1988, Arteriosclerosis.

[18]  N. Unwin,et al.  Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Detection, Evaluation, and Treatment of High Blood Cholesterol Education Program (NCEP) Expert Panel on Executive Summary of the Third Report of the National , 2009 .

[19]  H. Yamanaka,et al.  Estrogen treatment of prostate cancer increases triglycerides in lipoproteins as demonstrated by HPLC and immunoseparation techniques. , 2002, Clinica chimica acta; international journal of clinical chemistry.

[20]  S. Yamashita,et al.  Evaluation of an HPLC method for LDL-cholesterol determination in patients with various lipoprotein abnormalities in comparison with beta-quantification. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[21]  ShizuyaYamashita,et al.  Identification of Unique Lipoprotein Subclasses for Visceral Obesity by Component Analysis of Cholesterol Profile in High-Performance Liquid Chromatography , 2005 .

[22]  S. Yokoyama,et al.  Cholesteryl Ester Transfer Protein Expressed in Lecithin Cholesterol Acyltransferase–Deficient Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[23]  Ronald M. Lauer,et al.  National Cholesterol Education Program. Report of the Expert Panel on Population Strategies for Blood Cholesterol Reduction: executive summary. National Heart, Lung and Blood Institute, National Institutes of Health. , 1991, Archives of internal medicine.

[24]  M. Okazaki,et al.  Assessment of between-instrument variations in a HPLC method for serum lipoproteins and its traceability to reference methods for total cholesterol and HDL-cholesterol. , 2000, Clinical chemistry.

[25]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.

[26]  T. Teramoto,et al.  Scavenger receptor type BI potentiates reverse cholesterol transport system by removing cholesterol ester from HDL. , 2004, Atherosclerosis.

[27]  W C Willett,et al.  Low-density lipoprotein subclass patterns and risk of myocardial infarction. , 1988, JAMA.

[28]  I. Kubota,et al.  Component analysis of HPLC profiles of unique lipoprotein subclass cholesterols for detection of coronary artery disease. , 2006, Clinical Chemistry.

[29]  K. Hata,et al.  HPLC analysis of lipoproteins in culture medium of hepatoma cells: an in vitro system for screening antihyperlipidemic drugs , 2009, Biotechnology Letters.

[30]  K. Hata,et al.  In vitro screening for antihyperlipidemic activities in foodstuffs by evaluating lipoprotein profiles secreted from human hepatoma cells , 2011, Journal of Natural Medicines.